Magnesium Sulfate vs Placebo for Placental Abruption

Not Recruiting

Trial ID: NCT00186069


To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption.

Official Title

Randomized, Double Blind Trial of Magnesium Sulfate Tocolysis Versus Intravenous Saline for Suspected Placental Abruption

Stanford Investigator(s)

Yasser El-Sayed, Professor
Yasser El-Sayed, Professor

Charles B. and Ann L. Johnson Professor in the School of Medicine and Professor, by courtesy, of Pediatrics (Neonatology) and of Surgery


Inclusion Criteria:

- vaginal bleeding and contractions consistent with suspected placental abruption between
24 and 34 weeks gestation.

Exclusion Criteria:

- preterm labor, severe bleeding necessitating immediate delivery, maternal coagulopathy,
fetal distress


drug: Magnesium Sulfate

other: Normal Saline

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Iris Colon, MD
(408) 855-5550